Table 1.
Study | Type of research | Number of original studies (items) | Original study sample size (cases) | Interventions | Risk of bias assessment tool | Closing indicators | Main conclusions | |
---|---|---|---|---|---|---|---|---|
Control group | Test group | |||||||
Yu et al 15 | RCT | 19 | 1705 | Anthracycline-containing chemotherapy regimens | Anthracycline chemotherapy regimen + herbal injection | Cochrane Risk of Bias Assessment Tool | ②③④⑧⑨ | Chinese herbal injection is effective against cardiotoxicity caused by anthracycline chemotherapy regimen. |
Long et al 16 | RCT | 8 | 486 | Anthracycline-containing chemotherapy regimens | Anthracycline-based chemotherapy regimen + Ginseng-Qi Fuzheng injection | Cochrane Risk of Bias Assessment Tool | ③④⑧⑩ | Shenqi Fuzheng injection can improves cardiac function in patients on anthracycline chemotherapy regimens. |
Ma et al 17 | RCT | 8 | 660 | Anthracycline-containing chemotherapy regimens | Anthracycline-based chemotherapy regimen + cardiac veinron injection | Cochrane Risk of Bias Assessment Tool | ③④⑤⑥⑨ | Cardioplegia injection is effective in reducing the rate of ECG abnormalities in patients treated with anthracycline chemotherapy regimens. |
Zhang et al 18 | RCT | 12 | 775 | Anthracycline-containing chemotherapy regimens | Anthracycline chemotherapy regimen + Shenmai injection | Cochrane Risk of Bias Assessment Tool | ①② | Shenmai injection is effective in the treatment of acute leukemia and can alleviate the adverse effects caused by chemotherapy. |
Ma et al 19 | RCT | 10 | 612 | Anthracycline-containing chemotherapy regimen + dexrazoxane | Anthracycline chemotherapy regimen + dexraxozane + Shenmai injection | Cochrane Risk of Bias Assessment Tool | ③④⑧⑩ | Combination of dexrazoxane with Shenmai injection is superior to dexrazoxane alone in preventing anthracycline chemotherapy-induced cardiotoxicity. |
Yang et al 20 | RCT | 6 | 615 | Anthracycline-containing chemotherapy regimen + vitamin E and coenzyme Q, etc. | Anthracycline-containing chemotherapy regimens + Biovein injection | Cochrane Risk of Bias Assessment Tool | ③⑤⑥⑦ | Shengmai injection may prevent cardiotoxicity caused by anthracycline chemotherapy drugs. |
Li 21 | RCT | 24 | 1702 | Anthracycline-containing chemotherapy regimens | Anthracycline chemotherapy regimen + herbal injection | Jadad Scale | ③④⑧⑨ | Chinese herbal injections are protective against cardiotoxicity caused by anthracycline-based chemotherapy regimens |
① Clinical effective rate, ② Cardiac toxicity, ③ Abnormal rate of ECG, ④ Left ventricular ejection fraction, LVEF, ⑤ Change of left ventricular end diastolic diameter, LVIDD, ⑥ Change of left ventricular end systolic diameter, LVISD, ⑦ Change of left ventricular short axis shortening rate, FS, ⑧ Creatine kinase isoenzyme-MB, CK-MB, ⑨ Cardiac troponin I, cTnI, ⑩ Type B natriuretic peptide, BNP.
Abbreviations: RCT, randomized controlled trial.